BENEVICH ERIC bought NBIX
February 28, 2024 · Form 4 insider transaction
BENEVICH ERIC bought 53,143 shares of Neurocrine Biosciences, Inc. at $43.24 per share, a transaction worth $2.30M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
53,143
Price
$43.24
Total value
$2.30M
InsiderBENEVICH ERIC
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 28, 2024
Filing dateFebruary 29, 2024
Shares owned after93,759
OwnershipDirect
10b5-1 planNo
AmendedNo